Published in Placenta on December 11, 1992
The role of the placenta in fetal exposure to heavy metals. Wien Med Wochenschr (2012) 1.07
Maternal zinc intakes and homeostatic adjustments during pregnancy and lactation. Nutrients (2012) 0.86
Red blood cell metallothionein as an indicator of zinc status during pregnancy. Nutrition (2008) 0.78
Maternal iron metabolism gene variants modify umbilical cord blood lead levels by gene-environment interaction: a birth cohort study. Environ Health (2014) 0.77
Down-regulation of ABCG2 and ABCB4 transporters in the placenta of rats exposed to cadmium. Oncotarget (2016) 0.75
Methallothioneins and their role in the metabolism and toxicity of metals. Life Sci (1978) 2.03
Elastogenesis in human aorta: an electron microscopic study. Exp Mol Pathol (1965) 1.91
Fine fibrils of extracellular space (microfibrils). Their structure and role in connective tissue organization. Am J Pathol (1965) 1.63
Lead toxicity: current concerns. Environ Health Perspect (1993) 1.61
The secretory pathways of rat serum glycoproteins and albumin. Localization of newly formed proteins within the endoplasmic reticulum. J Cell Biol (1972) 1.60
Cadmium-metallothionein-induced nephropathy. Toxicol Appl Pharmacol (1976) 1.48
The morphogenesis and fate of potential and early atherosclerotic lesions in man. Hum Pathol (1971) 1.47
The fine structure of synovial lining cells in rheumatoid arthritis. Lab Invest (1966) 1.45
Transplacental transport of lead. Environ Health Perspect (1990) 1.44
Clearance of mercury (HG-197, HG-203) vapor inhaled by human subjects. Arch Environ Health (1977) 1.31
Radioactive mercury distribution in biological fluids and excretion in human subjects after inhalation of mercury vapor. Arch Environ Health (1978) 1.24
Isolation and purification of cadmium binding proteins from rat liver. Biochem Biophys Res Commun (1974) 1.24
Biliary excretion of cadmium in rat. I. Dose-dependent biliary excretion and the form of cadmium in the bile. J Toxicol Environ Health (1977) 1.18
Changes in the intracellular accumulation and distribution of metallothionein in rat liver and kidney during postnatal development. Dev Biol (1983) 1.16
The induced synthesis of metallothionein in various tissues of rat in response to metals. I. Effect of repeated injection of cadmium salts. Toxicology (1981) 1.14
Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay. Methods Enzymol (1991) 1.14
Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology (1982) 1.10
Yellow pulmonary hyaline membranes. J Pediatr (1976) 1.10
Lead toxicity: from overt to subclinical to subtle health effects. Environ Health Perspect (1990) 1.10
Metabolism of intravenously injected cadmium-binding protein. Biochem Biophys Res Commun (1975) 1.10
Mechanisms of lead and cadmium nephrotoxicity. Toxicol Lett (1989) 1.09
Placental weight in diabetic pregnancies. Placenta (1989) 1.08
Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells. Apoptosis (2005) 1.07
Mechanism of calcification in spontaneous aortic arteriosclerotic lesions of the rabbit. An electron microscopic study. Am J Pathol (1970) 1.07
Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of fetal human liver and kidney and its changes during development. Pathology (1987) 1.05
The induced synthesis of metallothionein in various tissues of rats in response to metals. II. Influence of zinc status and specific effect on pancreatic metallothionein. Toxicology (1982) 1.03
Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice. J Pharmacol Exp Ther (1996) 1.02
Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation. Cancer (1993) 1.01
Binding of manganese in human and rat plasma. Biochim Biophys Acta (1985) 1.01
Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals. Environ Health Perspect (1995) 1.00
Comparison of tissue distribution of cadmium in mice intravenously injected with metallothionein and a polymer of metallothionein. Toxicology (1983) 1.00
Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats. Toxicol Sci (2000) 0.98
Metallothionein in radiation exposure: its induction and protective role. Toxicology (1999) 0.98
Hyperornithinemia, hyperammonemia, and homocitrullinuria associated with decreased carbamyl phosphate synthetase I activity. Pediatr Res (1975) 0.98
Hyperpipecolatemia: A new metabolic disorder associated with neuropathy and hepatomegaly: A case study. Can Med Assoc J (1968) 0.98
Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration). Lab Invest (1987) 0.97
Preparation and properties of six rat hemoglobins. Nonuniform biosynthesis in marrow erythroid cells. J Biol Chem (1971) 0.97
Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells. Lab Invest (2000) 0.95
Biliary excretion of cadmium in rat. III. Effects of chelating agents and change in intracellular thiol content on biliary transport and tissue distribution of cadmium. J Toxicol Environ Health (1980) 0.95
Cellular adaptation in metal toxicology and metallothionein. Toxicology (1983) 0.95
Metallothioneins in brain--the role in physiology and pathology. Toxicol Appl Pharmacol (1997) 0.95
Smooth muscle cells in atherosclerosis. Monogr Atheroscler (1972) 0.94
Protective roles of metallothionein and glutathione in hepatotoxicity of cadmium. Toxicology (1992) 0.94
Reaction patterns of intimal mesenchyme to injury, and repair in atherosclerosis. Adv Exp Med Biol (1974) 0.93
Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br J Cancer (2002) 0.93
Candida albicans infection of the placenta and fetus. Report of a case. Obstet Gynecol (1967) 0.93
Metallothionein expression in renal cancer. Urology (1998) 0.92
Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from northern China. Anticancer Res (1999) 0.92
Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol (1991) 0.92
Formation of lead-induced inclusion bodies in primary rat kidney epithelial cell cultures: effect of actinomycin D and cycloheximide. Toxicol Appl Pharmacol (1980) 0.92
Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells. Virchows Arch A Pathol Anat Histopathol (1989) 0.92
Quantification of metallothioneins by a silver-saturation method. Toxicol Appl Pharmacol (1986) 0.92
A mutant mouse (tx) with increased hepatic metallothionein stability and accumulation. Biochem J (1993) 0.91
Hepatic metallothionein as a source of zinc and cysteine during the first year of life. Pediatr Res (1988) 0.91
Arsenic induces and enhances rat hepatic metallothionein production in vivo. Chem Biol Interact (1992) 0.91
Toxicological significance of metallothionein. Methods Enzymol (1991) 0.90
Immunohistochemical localization of metallothionein in human thyroid tumors. Am J Pathol (1987) 0.90
Metabolism and potential toxic effects of metallothionein. Experientia Suppl (1979) 0.90
Cadmium-induced enteropathy: comparative toxicity of cadmium chloride and cadmium-thionein. J Toxicol Environ Health (1977) 0.90
Absorption and tissue distribution of cadmium in mice after chronic feeding with cadmium chloride and cadmium-metallothionein. Bull Environ Contam Toxicol (1983) 0.90
Regulation of the ontogeny of rat liver metallothionein mRNA by zinc. Eur J Biochem (1987) 0.90
Metallothionein synthesis and localization in relation to metal storage in rat liver during gestation. Can J Biochem Cell Biol (1985) 0.89
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res (1994) 0.89
Effects of cadmium and zinc on tissue levels of metallothionein. Environ Health Perspect (1984) 0.88
Biochemical changes in rat kidney on exposure to elemental mercury vapor: effect on biosynthesis of metallothionein. Chem Biol Interact (1976) 0.88
Metallothionein and apoptosis during differentiation of myoblasts to myotubes: protection against free radical toxicity. Toxicol Appl Pharmacol (1999) 0.88
The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney. Toxicology (1990) 0.88
Ascorbic acid and EDTA treatment of lead toxicity in rats. Life Sci (1979) 0.88
Variations in the aortic origin of intercostal arteries in man. Anat Rec (1979) 0.88
Further evidence of the tumor-suppressive effects of cadmium in the B6C3F1 mouse liver and lung: late stage vulnerability of tumors to cadmium and the role of metallothionein. J Pharmacol Exp Ther (1993) 0.87
Increased expression of tissue inhibitor of metalloproteinases (TIMP-I) and metallothionein in murine lungs after hyperoxic exposure. Am J Respir Cell Mol Biol (1994) 0.87
Comparison of metallothionein determination by polarographic and cadmium-saturation methods. Toxicol Appl Pharmacol (1982) 0.86
Roles of vitamin C in radiation-induced DNA damage in presence and absence of copper. Chem Biol Interact (2001) 0.86
Basement membranes (amniotic, trophoblastic, capillary) and adjacent tissue in term placenta. An electron microscopic study. Am J Obstet Gynecol (1967) 0.85
Transplacental transfer of cadmium and fetal effects. Fundam Appl Toxicol (1991) 0.85
Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. Chem Biol Interact (1995) 0.85
Isolation & characterization of a new glycopeptide containing hydroxyproline from human urine. Indian J Biochem (1966) 0.85
Myopathy in primary familial hyperparathyroidism. Clinical and morphologic studies. Am J Med (1970) 0.85
Rat kidney epithelial cell culture for metal toxicity studies. In Vitro Cell Dev Biol (1985) 0.85
Chelation of cadmium with BAL and DTPA in rats. Nature (1980) 0.85
Biliary excretion of cadmium in rat. II. The role of metallothionein in the hepatobiliary transport of cadmium. J Toxicol Environ Health (1977) 0.85
Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen. Clin Invest Med (1997) 0.85
The influence of manganese on the distribution of essential trace elements. II. The tissue distribution of manganese, magnesium, zinc, iron, and copper in rats after chronic manganese exposure. J Toxicol Environ Health (1984) 0.85
Gastrointestinal absorption and organ distribution of oral cadmium chloride and cadmium-metallothionein in mice. J Toxicol Environ Health (1979) 0.85
Keratoplasty and electron microscopy of the cornea in systemic mucopolysaccharidosis (Hurler's disease). Can J Ophthalmol (1968) 0.85
Exposure to different forms of cadmium in mice: differences in metallothionein and alphafetoprotein mRNA induction in liver and kidney. J Biochem Toxicol (1988) 0.85
Metallothionein and apoptosis in the toxic milk mutant mouse. Lab Invest (1998) 0.84
Electron microscopic studies of fibrinoid. Laval Med (1968) 0.84
Chemical modifications of metallothionein. Preparation and characterization of polymers. Biochem J (1984) 0.84
Metallothionein levels in liver and kidney of Canadians--a potential indicator of environmental exposure to cadmium. Arch Environ Health (1987) 0.84
Placental inflammation and infection. A prospective bacteriologic and histologic study. Am J Obstet Gynecol (1966) 0.84
Protective effects of metallothionein on streptozotocin-induced diabetes in rats. Life Sci (1994) 0.84
Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome. Cancer (2001) 0.84
Unusual clinical and ultrastructural features in a boy with biochemically typical mannosidosis. Acta Paediatr Scand (1980) 0.83
Metallothionein induction in human CNS in vitro: neuroprotection from ionizing radiation. Int J Radiat Biol (2000) 0.83
Mitochondrial budding and morphogenesis of cytoplasmic vacuoles in hepatocytes of children with the Hurler syndrome and Sanfilippo disease. Exp Mol Pathol (1968) 0.83
Quantification of metallothionein by silver saturation. Methods Enzymol (1991) 0.83
Clinicopathological conference: an adolescent girl with severe mental impairment and mucopolysacchariduria. Am J Med Genet (1985) 0.83
A patient with tyrosinemia and hypermethioninemia. Can Med Assoc J (1967) 0.83
Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats. Toxicol Appl Pharmacol (1993) 0.82